Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

14 septembre 2017

16:32
SAN DIEGO, Sept. 14, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology biotechnology company, announced that positive preliminary data from two ongoing clinical trials of sitravatinib in non-small cell...

16:03
HORSHAM, Pa., Sept. 14, 2017 /PRNewswire/ -- Janssen Biotech, Inc. today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking to expand the indication of ZYTIGA® in combination...

15:34
- Two-year data from the ILLUMENATE European randomized clinical trial (EU RCT) validates durable clinical performance of Stellarex low-dose drug-coated balloon - Trial includes 328 peripheral arterial disease patients from 18 centers across...

12:51
PITTSBURGH, Sept. 14, 2017 /PRNewswire/ -- The UPMC Center for High-Value Health Care today announced it has been approved for a $3.8 million funding award by the Patient-Centered Outcomes Research Institute (PCORI). This announcement marks the third...

11:20
BRUXELLES, September 14, 2017 /PRNewswire/ -- Les résultats présentés à la rencontre annuelle de l'EASD par Young et al. ne sont pas étayés par un certain nombre d'études antérieures menées par le même groupe de recherche   En réponse à un...

10:45
SILVER SPRING, Md., Sept. 14, 2017 /PRNewswire-USNewswire/ -- Today, the U.S. Food and Drug Administration permitted marketing of the first mobile medical application to help treat substance use disorders (SUD). The Reset application is intended to...

10:25
WASHINGTON, Sept. 14, 2017 /PRNewswire/ -- An investigational treatment that mimics a key clotting enzyme is effective, safe, and may one day eliminate the need for blood products for people with the rare, life-threatening blood disease hereditary...

10:00
LEXINGTON, Mass., Sept. 14, 2017 /PRNewswire/ -- G3 Pharmaceuticals, a newly formed biopharmaceutical company located in Lexington, MA, today announced the start of its research and development program to pursue novel galectin-3 inhibitors.  ...

09:00
ATLANTA, Sept. 14, 2017 /PRNewswire/ -- Global Genomics Group (G3), a leading precision-medicine based biopharmaceutical company and Semmelweis University in Budapest, Hungary, today announced that they have uncovered the degree of genetic...

09:00
INDIANAPOLIS, Sept. 14, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announced new safety and efficacy data from a Phase 2 study of baricitinib in people with moderate-to-severe atopic dermatitis...

08:29
BRUSSELS, September 14, 2017 /PRNewswire/ -- Study findings presented at EASD annual meeting by Young et al. are not supported by a number of earlier studies by the same research group  In response to a press release issued in light of the...

08:15
DENVER, Sept. 14, 2017 /PRNewswire/ -- Telos Partners, LLC, a firm providing scientific, regulatory and publication services to the life sciences industry, has been selected by Acera Surgical to lead its Restratatm wound matrix study titled:...

07:55
HAMILTON, Bermuda, and NEW YORK, Sept. 14, 2017 /PRNewswire/ -- SELLAS Life Sciences Group Ltd. (SELLAS), a privately-held, oncology-focused, clinical stage biopharmaceutical company, today reported that its WT1-targeting immuno-oncology (IO)...

07:00
PETACH TIKVA, Israel, September 14, 2017 /PRNewswire/ -- OWC Pharma (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today issued a letter to shareholders.      (Logo:...

07:00
CALGARY and SAN DIEGO, Sept. 14, 2017 /PRNewswire/ - Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF) (Oncolytics or the Company), a biotech company developing REOLYSIN® (pelareorep), a first-in-class, systemically delivered immuno-oncolytic virus...

07:00
LISBON, Portugal, Sept. 14, 2017 /PRNewswire/ -- A new randomized clinical trial, TAKE CONTROL1, demonstrated better control of blood sugar (HbA1c) without increasing the risk of hypoglycemia in people with type 2 diabetes (T2D) by using Toujeo®...

06:46
LISBONNE, Portugal, September 14, 2017 /PRNewswire/ -- Aujourd'hui, au cours de la 53e assemblée annuelle de l'Association Européenne pour l'étude du diabète (EASD), Ascensia Diabetes Care a annoncé le lancement de l'Ascensia Diabetes Challenge, un...

05:00
NEW YORK and TOKYO, Sept. 14, 2017 /PRNewswire/ -- Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") announced today that the Phase 3 PROSPER trial evaluating XTANDI® (enzalutamide) plus...


13 septembre 2017

17:29
LAS VEGAS, Sept. 13, 2017 /PRNewswire-USNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the final five of 20 highly...

16:43
TEL AVIV, Israel, Sept. 13, 2017 /PRNewswire/ -- Carevature Medical Ltd., developer of advanced orthopedic and neurological surgery solutions, announces the preliminary clinical results of its Drealtm spinal decompression and bone removal system. The...

16:04
WASHINGTON, Sept. 13, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced results from an 8-week randomized Phase II clinical study of tradipitant as a monotherapy in the treatment of chronic pruritus in patients...

13:10
BALTIMORE, Sept. 13, 2017 /PRNewswire/ -- AgeneBio, a pharmaceutical company developing innovative therapeutics for unserved patients battling neurodegeneration, today announced it has been awarded a grant for up to $10 million from the National...

12:52
LAUSANNE, Switzerland, September 13, 2017 /PRNewswire/ -- The Journal of American Academy of Dermatology recently published "The Efficacy of Autologous platelet-rich plasma combined with hyaluronic acid on skin facial rejuvenation: A prospective...

11:00
HAYWARD, Calif., Sept. 13, 2017 /PRNewswire/ -- Research published today in Scientific Reports shows that light from RayVio's 293nm ultraviolet (UV) LED is more efficient than sunlight at producing vitamin D3 in skin samples. Tyler Kalajian and his...

10:52
NEW YORK, Sept. 13, 2017 /PRNewswire-USNewswire/ -- Nearly 200 academic and industry researchers came together to share updates on preclinical and clinical-stage Alzheimer's disease research at the 18th Annual Conference on Alzheimer's Drug...

10:31
LISBON, Portugal, September 13, 2017 /PRNewswire/ -- Oral Presentation 113  In people with type 2 diabetes, Xultophy® (insulin degludec/liraglutide) significantly reduced a number of risk factors associated with an increased risk of cardiovascular...

10:09
ROCKVILLE, Md., Sept. 13, 2017 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that the...

09:12
OSAKA, Japan, Sept. 13, 2017 /PRNewswire/ -- Results of a S-033188 Phase 3 study in influenza patients (CAPSTONE-1) were released at the 6th European Scientific Working Group on Influenza Conference (ESWI), held on September 10-13, 2017 in Riga,...

09:00
LISBON, Portugal, September 13, 2017 /PRNewswire/ -- Today, during the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD), Ascensia Diabetes Care announced the launch of the Ascensia Diabetes Challenge, a global...

08:51
RALEIGH, Caroline du Nord, 13 septembre 2017 /PRNewswire/ -- Aujourd'hui, Contego Medical, LLC a annoncé le lancement de l'étude ENTRAP qui évaluera son système d'angioplastie périphérique par ballonnet Vanguard IEP®, doté de la technologie...

08:35
PLEASANTON, Calif., Sept. 13, 2017 /PRNewswire/ -- Duke University School of Nursing researchers have launched a five-year study to determine optimal timing for turning or repositioning patients to reduce the risk of pressure ulcers, which affect up...

08:30
MEDFORD, Mass., Sept. 13, 2017 /PRNewswire/ -- GreenLight Biosciences, Inc. announced today the completion of its $18 million Series D round of financing led by Fall Line Capital. S2G Ventures, Lewis and Clark Ventures, and Macro Capital Investments...

08:14
EPALINGES, Switzerland, Sept. 13, 2017 /PRNewswire/ -- Mymetics Corporation (OTCQB: MYMX), a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases, announced today that they will...

08:00
SAN DIEGO, Sept. 13, 2017 /PRNewswire/ -- Geom Therapeutics, Inc., today announced a Clinical Trial Agreement (CTA) with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to conduct a...

08:00
IRVINE, Calif., Sept. 13, 2017 /PRNewswire/ -- Bioniz Therapeutics, Inc., a clinical stage biopharmaceutical company leading the discovery and development of first-in-class peptide therapeutics that selectively and simultaneously inhibit multiple...

08:00
SAN BRUNO, Calif. and HONOLULU, Sept. 13, 2017 /PRNewswire/ -- Neuraltus Pharmaceuticals, Inc., a privately held biopharmaceutical company dedicated to developing innovative therapeutics for neurodegenerative diseases, and the John A. Burns School of...

07:00
LISBON, Portugal, Sept. 13, 2017 /PRNewswire-USNewswire/ -- In a new analysis1 of late stage clinical trials,2-4 adults with type 2 diabetes treated with Sanofi's Toujeo® (insulin glargine 300 Units/mL, Gla-300) achieved better blood glucose...

06:00
« Cette nouvelle technologie va changer la vie de nos patients » Dr Louis P. Perrault, chef du département de chirurgie cardiaque, Institut de Cardiologie de Montréal MONTRÉAL, le 13 sept. 2017 /CNW Telbec/ - L'Institut de Cardiologie de Montréal...

06:00
"This new technology will change the lives of our patients" Dr. Louis P. Perrault, Head of the Department of Cardiac Surgery, Montreal Heart Institute MONTREAL, Sept. 13, 2017 /CNW Telbec/ - The Montreal Heart Institute (MHI) is proud to announce...

04:31
THE WOODLANDS, Texas, Sept. 13, 2017 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the New England Journal of Medicine (NEJM) published the results of the Phase 3 inTandem3 study of sotagliflozin,...

02:45
LAUSANNE, Switzerland, September 13, 2017 /PRNewswire/ -- The Journal of American Academy of Dermatology, recently issued "the Efficacy of Autologous platelet-rich plasma combined with hyaluronic acid on skin facial rejuvenation: A prospective...

02:43
LUND, Sweden, Sept. 13, 2017 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that a research collaboration agreement...

01:45
LAUSANNE, Suisse, September 13, 2017 /PRNewswire/ -- Le Journal de l'Académie Américaine de Dermatologie « JAAD » a récemment publié un article en référence à l'étude clinique «L'efficacité du plasma autologue enrichi en plaquettes combiné avec...

01:34
EAST HANOVER, N.J., Sept. 13, 2017 /PRNewswire/ -- Novartis announced today first of its kind Phase III data showing Cosentyx® (secukinumab) delivered high and long-lasting skin clearance in patients with moderate to severe plaque psoriasis at 5...

01:00
VANCOUVER, Canada, September 13, 2017 /PRNewswire/ -- Highlights:   A new robotic vial filling machine for clinical trials and product development of biopharmaceuticals, cell therapies and personalized medicines.   Microcell makes it...

01:00
VANCOUVER, Canada, September 13, 2017 /PRNewswire/ -- Principaux éléments :    Une machine de remplissage des flacons utilisant la robotique, destinée aux études cliniques et au développement de produits pharmaceutiques, aux thérapies cellulaires...


12 septembre 2017

17:10
LAS VEGAS, Sept. 12, 2017 /PRNewswire-USNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the second five of twenty 20 highly...

13:59
ARLINGTON, Va., Sept. 12, 2017 /PRNewswire-USNewswire/ -- The press program for the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO) will feature advances in cancer research, including reports from phase II and III clinical...

13:30
MADRID, September 12, 2017 /PRNewswire/ -- PharmaMar (MSE: PHM) presented during the European Society for Medical Oncology congress (ESMO), held in Madrid, positive results of PM1183 (lurbinectedin) in a cohort of 36 patients as monotherapy in...

12:50
LAS VEGAS, Sept. 12, 2017 /PRNewswire-USNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced the first five of 20 highly...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19